CPHI vs RTX · rev $4.1M vs P/E 36, rev $88.60B
China Pharma Holdings Inc (CPHI) versus RTX Corporation (RTX) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported RTX revenue for 2025-12-31 was $88.60B. Net income was $6.73B. Revenue was up 9.7% from 2024-12-31 to 2025-12-31. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
CPHI currently screens at market cap $29.0M. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Not investment advice. Open the CPHI and RTX stock pages for the full models.
Not investment advice.